Advertisement

Ipotiroidismo nel paziente anziano: quando e come trattare?

  • Filippo Niccolai
  • Alessia M. Calabrese
  • Giuseppe Pasqualetti
  • Antonio Polini
  • Sara Tognini
  • Nadia Caraccio
  • Fabio MonzaniEmail author
Rassegna
  • 11 Downloads

Sommario

L’ipotiroidismo è frequente negli anziani ed è noto l’incremento del TSH con l’invecchiamento. Un valore di TSH >10 mU/L è generalmente rilevante. La necessità di terapia sostitutiva con LT4 va valutata caso per caso, bilanciando attentamente i rischi e i benefici del trattamento e ponendo al centro dell’iter diagnostico-terapeutico non solo i livelli di TSH circolante, ma anche la presenza o meno di una effettiva patologia tiroidea così come le comorbidità e l’eventuale presenza di “fragilità”.

Parole chiave

Ipotiroidismo Levotiroxina Invecchiamento Fragilità Terapia 

Supplementary material

40619_2019_517_MOESM1_ESM.docx (18 kb)
Scheda di autovalutazione (DOCX 18 kB)
40619_2019_517_MOESM2_ESM.docx (16 kb)
RISPOSTE (DOCX 16 kB)

Bibliografia

  1. 1.
    Boelaert K (2013) Thyroid dysfunction in the elderly. Nat Rev Endocrinol 9(4):194–204 CrossRefGoogle Scholar
  2. 2.
    The Medicines Utilization Monitoring Centre (2017) National report on medicines use in Italy 2016. Italian Medicines Agency, Rome, p 39 Google Scholar
  3. 3.
    Cooper DS, Biondi B (2012) Subclinical thyroid disease. Lancet 379(9821):1142–1154 CrossRefGoogle Scholar
  4. 4.
    Pearce SH, Brabant G, Duntas LH et al. (2013) 2013 ETA guideline: management of subclinical hypothyroidism. Eur Thyroid J 2(4):215–228 CrossRefGoogle Scholar
  5. 5.
    Taylor PN, Albrecht D, Scholz A et al. (2018) Global epidemiology of hyperthyroidism and hypothyroidism. Nat Rev Endocrinol 14(5):301–316 CrossRefGoogle Scholar
  6. 6.
    Solini A, Monzani F (2010) Hypothyroidism and intermediate metabolism: a complex relationship. Thyroid 20(8):837–839 CrossRefGoogle Scholar
  7. 7.
    Pasqualetti G, Tognini S, Polini A et al. (2013) Is subclinical hypothyroidism a cardiovascular risk factor in the elderly? J Clin Endocrinol Metab 98(6):2256–2266 CrossRefGoogle Scholar
  8. 8.
    Mariotti S, Franceschi C, Cossarizza A, Pinchera A (1995) The aging thyroid. Endocr Rev 16(6):686–715 CrossRefGoogle Scholar
  9. 9.
    Chaker L, Wolters FJ, Bos D et al. (2016) Thyroid function and the risk of dementia: The Rotterdam Study. Neurology 87(16):1688–1695 CrossRefGoogle Scholar
  10. 10.
    Bremner AP, Feddema P, Leedman PJ et al. (2012) Age-related changes in thyroid function: a longitudinal study of a community-based cohort. J Clin Endocrinol Metab 97(5):1554–1562 CrossRefGoogle Scholar
  11. 11.
    Jonklaas J, Bianco AC, Bauer AJ et al. (2014) Guidelines for the treatment of hypothyroidism: prepared by the American Thyroid Association task force on thyroid hormone replacement. Thyroid 24(12):1670–1751 CrossRefGoogle Scholar
  12. 12.
    Ruggeri RM, Trimarchi F, Biondi B (2017) Management of endocrine 534 disease: l-Thyroxine replacement therapy in the frail elderly: a challenge in clinical practice. Eur J Endocrinol 177(4):R199–R217 CrossRefGoogle Scholar
  13. 13.
    Stott DJ, Rodondi N, Bauer DC (2017) Thyroid hormone therapy for older adults with subclinical hypothyroidism. N Engl J Med 377(14):20 CrossRefGoogle Scholar
  14. 14.
    Pasqualetti G, Tognini S, Polini A et al. (2013) Subclinical hypothyroidism and heart failure risk in older people. Endocr Metab Immune Disord Drug Targets 13(1):13–21 CrossRefGoogle Scholar
  15. 15.
    Ruggeri RM, Trimarchi F, Biondi B (2017) Management of endocrine 534 disease: l-Thyroxine replacement therapy in the frail elderly: a challenge in clinical practice. Eur J Endocrinol 177(4):R199–R217 CrossRefGoogle Scholar
  16. 16.
    Pasqualetti G, Calsolaro V, Bernardini S et al. (2018) Degree of peripheral thyroxin deiodination, frailty, and long-term survival in hospitalized older patients. J Clin Endocrinol Metab 103(5):1867–1876 CrossRefGoogle Scholar
  17. 17.
    Virili C, Giovanella L, Fallahi P et al. (2018) Levothyroxine therapy: changes of TSH levels by switching patients from tablet to liquid formulation. A systematic review and meta-analysis. Front Endocrinol 9:10 CrossRefGoogle Scholar
  18. 18.
    Grozinsky-Glasberg S, Fraser A, Nahshoni E et al. (2006) Thyroxine-triiodothyronine combination therapy versus thyroxine monotherapy for clinical hypothyroidism: meta- analysis of randomized controlled trials. J Clin Endocrinol Metab 91(7):2592–2599 CrossRefGoogle Scholar
  19. 19.
    Leese GP, Soto-Pedre E, Donnelly LA (2016) Liothyronine use in a 17-year observational population-based study—the tears study. Clin Endocrinol 85(6):918–925 CrossRefGoogle Scholar
  20. 20.
    Biondi B, Bartalena L, Chiovato L et al. (2016) Recommendations for treatment of hypothyroidism with levothyroxine and levotriiodothyronine: a 2016 position statement of the Italian Society of Endocrinology and the Italian Thyroid Association. J Endocrinol Invest 39(12):1465–1474 CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Filippo Niccolai
    • 1
  • Alessia M. Calabrese
    • 1
  • Giuseppe Pasqualetti
    • 1
  • Antonio Polini
    • 1
  • Sara Tognini
    • 1
  • Nadia Caraccio
    • 1
  • Fabio Monzani
    • 1
    Email author
  1. 1.Unità di Geriatria, Dipartimento di Medicina Clinica e SperimentaleUniversità di PisaPisaItalia

Personalised recommendations